Yini Zhu
Nanjing, 210009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Glycerol-mediated nose-to-brain codelivery of anti-IL-17 and anti-CD73 antibodies enhances immunotherapy for melanoma brain metastases.
Journal: Science advances
Published: May 13, 2026
Enhancing Breast Cancer Immunotherapy by Suppressing Sympathetic Nervous System-Driven T-Cell Exhaustion and Promoting T-Cell Priming and Trafficking.
Journal: ACS nano
Published: December 23, 2025
HOXD11-NMDAR signaling drives neuroendocrine prostate cancer and enables potential therapeutic intervention as a target of memantine.
Journal: Cell reports
Published: December 16, 2025
Low-intensity pulsed ultrasound-mediated nose-to-brain co-delivery of β-blockers and aPD-L1 enhances glioblastoma immunotherapy.
Journal: Nature communications
Published: October 16, 2025
Enhancing TIM-3 immunotherapy with epirubicin-loaded pH sensitive fusion membrane nanoparticles for effective glioblastoma treatment.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: September 01, 2025
Co-delivering macrophage engager mRNA and PD-L1 antibody via tumor-responsive nanoparticles for glioblastoma immunotherapy.
Journal: Nature communications
Published: August 14, 2025
The efficacy and safety of Chinese herbal medicine Shugan Sanjie decoction in the treatment of uterine fibroids: a systematic review and meta-analysis.
Journal: Frontiers in pharmacology
Published: October 08, 2024
Open-Source Throttling of CD8+ T Cells in Brain with Low-Intensity Focused Ultrasound-Guided Sequential Delivery of CXCL10, IL-2, and aPD-L1 for Glioblastoma Immunotherapy.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: May 21, 2024
Showing 1-10 of 10
Last Updated: 09/26/2026